Pleural Neoplasms

"Pleural Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.

Descriptor ID	D010997
MeSH Number(s)	C04.588.894.797.640 C08.528.694 C08.785.640
Concept/Terms	Pleural Neoplasms Pleural Neoplasms Neoplasms, Pleural Neoplasm, Pleural Pleural Neoplasm

Below are MeSH descriptors whose meaning is more general than "Pleural Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Thoracic Neoplasms [C04.588.894]
Respiratory Tract Neoplasms [C04.588.894.797]
Pleural Neoplasms [C04.588.894.797.640]
Respiratory Tract Diseases [C08]
Pleural Diseases [C08.528]
Pleural Neoplasms [C08.528.694]
Respiratory Tract Neoplasms [C08.785]
Pleural Neoplasms [C08.785.640]

Below are MeSH descriptors whose meaning is related to "Pleural Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Pleural Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pleural Neoplasms" by people in this website by year, and whether "Pleural Neoplasms" was a major or minor topic of these publications.

Bar chart showing 48 publications over 17 distinct years, with a maximum of 7 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	2	1	3
2003	1	0	1
2004	7	0	7
2005	1	0	1
2006	3	0	3
2007	0	1	1
2008	5	0	5
2009	3	0	3
2010	3	1	4
2011	1	1	2
2012	2	0	2
2014	3	0	3
2015	5	0	5
2016	4	0	4
2017	0	1	1
2019	2	0	2
2020	0	1	1

Below are the most recent publications written about "Pleural Neoplasms" by people in Profiles.

Pass HI, Alimi M, Carbone M, Yang H, Goparaju CM. Mesothelioma Biomarkers: Discovery in Search of Validation. Thorac Surg Clin. 2020 Nov; 30(4):395-423.

View in: PubMed
Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019 09; 69(5):402-429.

View in: PubMed
Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, Nowak A, Peikert T, Salgia R, Szlosarek P, Taioli E, Yang H, Tsao A, Mansfield AS. Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. J Thorac Oncol. 2019 10; 14(10):1704-1717.

View in: PubMed
Carbone M, Guo Z, Mao W. Improving the Accuracy of?Mesothelioma Diagnosis in China. J Thorac Oncol. 2017 08; 12(8):e132.

View in: PubMed
Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, Gao Z, Shao D, Chen J, Zhang G, Hu J, Chen K, Wang F, Pass HI, Yu H, Napolitano A, Yang H, Mao W. Improving the Accuracy of Mesothelioma Diagnosis in China. J Thorac Oncol. 2017 04; 12(4):714-723.

View in: PubMed
Carbone M, Shimizu D, Napolitano A, Tanji M, Pass HI, Yang H, Pastorino S. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma. Oncotarget. 2016 Sep 13; 7(37):59314-59321.

View in: PubMed
Pass HI, Goparaju C, Espin-Garcia O, Donington J, Carbone M, Patel D, Chen Z, Feld R, Cho J, Gadgeel S, Wozniak A, Chachoua A, Leighl N, Tsao MS, de Perrot M, Xu W, Liu G. Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.

View in: PubMed
Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass HI, Carbone M, Yang H. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients. Clin Cancer Res. 2016 06 15; 22(12):3087-96.

View in: PubMed
Taioli E, Wolf AS, Camacho-Rivera M, Kaufman A, Lee DS, Nicastri D, Rosenzweig K, Flores RM. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients. PLoS One. 2015; 10(12):e0145039.

View in: PubMed
Bononi A, Napolitano A, Pass HI, Yang H, Carbone M. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. Expert Rev Respir Med. 2015 Oct; 9(5):633-54.

View in: PubMed

People

Explore

Similar Concepts

Top Journals